In this Behind the Breakthroughs episode, @ayzhou.bsky.social argues that nonprofits play a unique role: funding shared infrastructure, driving standardization, and enabling collaboration at scale.

Apple Podcasts link: tinyurl.com/IPMsBTBonAP

Spotify link: tinyurl.com/IPMsBTBonSpo...

Behind the Breakthroughs Technology Podcast · Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution...

Brad Ringeisen, Executive Director at @innovativegenomics.bsky.social, shares his journey, from chemist to DARPA to working w/ #CRISPR legend Jennifer Doudna.

Apple Podcasts tinyurl.com/IPMsBTBonAP

Spotify tinyurl.com/IPMsBTBonSpo...

shows.acast.com/behind-the-b...

@ucblaborcenter.bsky.social

Shana Kelley: Instrumented Tissues for Monitoring Human Body in Real-Time The director at the Chan Zuckerberg Biohub Chicago shares how researchers are paving the way for implanted diagnostics for inflammation and more.

Shana Kelley, PhD, President of the Chan Zuckerberg (@chanzuckerberg.bsky.social) Biohub Chicago, is advancing “instrumented tissues” to precisely measure biological processes. Learn more about her groundbreaking work on this episode of Behind the Breakthroughs. tinyurl.com/3betkes4

Hear David Liu share his approach/philosophy to solving biological problems on IPM's BTB podcast

Apple podcast link:
itunes.apple.com/us/podcast/i...

Spotify link: open.spotify.com/show/03X80PT...

Acast: shows.acast.com/67105af84872...

@broadinstitute.bsky.social
@harvard.edu
@broadinstitute.org

My Personal Genomics Journey in 23andMe’s Resurrection Era This three-part series examines the current paths for sequencing, analyzing, and utilizing an individual’s genome to guide healthcare decisions.

SEEKING TESTIMONIALS ON PERSONAL GENOMIC TESTING FOR MAGAZINE SERIES

If you’ve done DTC (e.g., Nucleus Genomics) or clinician initiated testing and want to share your experience (good or bad) or questions/concerns, DM or email me.

Here’s part 1:

www.insideprecisionmedicine.com/topics/preci...

That is a heavy duty article. I’m going to need to sit down for a minute before getting back to you on it.

On Thursday, the NIH dropped 2 news bombs: ending funding for animal-only research to prioritize human studies & publishing more >200 complete response letters to FDA applications for drugs/biologics during 2020-2024.

I want to hear your thoughts! DM, post, email...

@altnih4science.bsky.social

More than a Feeling: Predicting Biology with Spatiotemporal Multiomics | Behind the Breakthroughs Mike Previte, PhD [Element Biosciences]

Mike Previte, Element Biosciences cofounder/CTO, is (Good) Will Hunting IRL. Check out Mike discuss why and how he's developing tools like 5D single-cell multiomics in the latest IPM "Behind The Breakthroughs" episode out now!

@elembio.bsky.social
@sagepub.com

shows.acast.com/67105af84872...

Allogeneic NK Cells Are Coming to Beat Cancer at a Clinic Near You | Behind the Breakthroughs Katy Rezvani, MD, PhD [MD Anderson Cancer Center]

In this episode, cell therapy expert Katy Rezvani, MD, PhD, (@mdanderson.bsky.social) tells me why she loves NK cells & the ways they’re being engineered to treat cancer and other diseases as accessible and affordable cell tx.

shows.acast.com/67105af84872...

Oxford Nanopore CEO Looks Beyond Native DNA, RNA Sequencing “I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the t...

Exclusive interview with Gordon Sanghera, CEO @oxfordnanopore.bsky.social, by my colleagues Alex Philippidis and @grinsteinj.bsky.social at JPM.
Life after Clive Brown and many other topics...
www.genengnews.com/topics/omics...

Have been on Bluesky quite a bit the last two days (for info & resources) & it’s not social media that’s broken. I think it’s us that’s broken now. I’ll post about places ppl can donate because LA is in bad shape & my replies are full of “ummmm sounds like somebody’s never heard of Pompeii.”

Carrying Medicine Into the Post-Moore’s Law Era | Behind the Breakthroughs Harry Clifford, PhD [NVIDIA]

Obligatory “Hello World.”

1: I think it’s amazing that @bsky.app took twitter’s colors and chose a metamorphosed flying creature.

2: If you haven't heard what NVIDIA is doing in R&D and healthcare, it's time you find out. Check out the latest episode of my podcast:

shows.acast.com/67105af84872...